INS and Hyperglycemia: The International Diabetes Federation predicts that global prevalence of adults living with Type 2 diabetes (T2D) will increase from approximately 536 million to 783 million by 2045.1 T2D is a metabolic disorder characterized by hyperglycemia due to insufficient insulin secretion from pancreatic β-cells and/or peripheral insulin resistance.